- Home
- TBRG vs HRTX Comparison
TBRG vs HRTX Comparison
Compare TBRG & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBRG
- HRTX
- Stock Information
- Founded
- TBRG 1979
- HRTX 1983
- Country
- TBRG United States
- HRTX United States
- Employees
- TBRG N/A
- HRTX N/A
- Industry
- TBRG
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- TBRG
- HRTX Health Care
- Exchange
- TBRG NYSE
- HRTX Nasdaq
- Market Cap
- TBRG 271.5M
- HRTX 240.3M
- IPO Year
- TBRG N/A
- HRTX 1987
- Fundamental
- Price
- TBRG $18.60
- HRTX $1.59
- Analyst Decision
- TBRG Buy
- HRTX Strong Buy
- Analyst Count
- TBRG 3
- HRTX 3
- Target Price
- TBRG $14.67
- HRTX $5.67
- AVG Volume (30 Days)
- TBRG 66.0K
- HRTX 6.2M
- Earning Date
- TBRG 11-07-2024
- HRTX 11-12-2024
- Dividend Yield
- TBRG N/A
- HRTX N/A
- EPS Growth
- TBRG N/A
- HRTX N/A
- EPS
- TBRG N/A
- HRTX N/A
- Revenue
- TBRG $337,674,000.00
- HRTX $137,737,000.00
- Revenue This Year
- TBRG $1.01
- HRTX $13.10
- Revenue Next Year
- TBRG $6.05
- HRTX $18.76
- P/E Ratio
- TBRG N/A
- HRTX N/A
- Revenue Growth
- TBRG 0.26
- HRTX 12.13
- 52 Week Low
- TBRG $7.55
- HRTX $1.04
- 52 Week High
- TBRG $18.83
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- TBRG 63.03
- HRTX 50.28
- Support Level
- TBRG $17.71
- HRTX $1.53
- Resistance Level
- TBRG $18.47
- HRTX $1.88
- Average True Range (ATR)
- TBRG 0.60
- HRTX 0.17
- MACD
- TBRG -0.19
- HRTX 0.01
- Stochastic Oscillator
- TBRG 35.32
- HRTX 47.67
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.